NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
$153.81 2.69 (1.78%)
Analysed NOVARTIS AG-SPONSORED ADR (NVS:NYSE) News Sources
Valiant Holding (SWX:VATN) Stock Could Trade At A Discount On Capital Returns
27-10-2026
yahoo.com
OHB (XTRA:OHB) Stock May Be 16% Undervalued Following ESA Lunar Study Contract
27-10-2026
yahoo.com
Novartis MS drug remibrutinib cuts relapses, no liver safety signal in trials
26-10-2026
yahoo.com
Novartis Reports Lower Relapse Rates and No Hy’s Law Cases in Phase 3 Remibrutinib MS Trials
26-10-2026
advfn.com
Top Analyst Reports for Intel, Novartis & Itau Unibanco
26-10-2026
yahoo.com
Novartis (SWX:NOVN) Advances Two Key Growth Drugs With New Late Stage Data
26-10-2026
yahoo.com
Novartis (SWX:NOVN) Gains Fresh Trial Focus, Is The Good News Already Priced In?
27-10-2026
yahoo.com
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
27-10-2026
yahoo.com
Novartis: Q3 Earnings Snapshot
27-10-2026
yahoo.com
Novartis raises annual profit outlook after strong Q3 sales growth
27-10-2026
yahoo.com
What is the current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is $153.81.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) absolute price change since previous trading day?
The absolute price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is $2.69.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) percentage price change since previous trading day?
The percentage price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is 1.78%.
What is the most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is 53 out of 100.
What is the most recent average sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is .
SEC-8K** Filing Available For NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.